Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

2.

Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.

Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, Chen YH, Zhang XH, Lu DP.

Biol Blood Marrow Transplant. 2009 Feb;15(2):257-65. doi: 10.1016/j.bbmt.2008.11.025.

3.

A male-specific increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL.

Dorak MT, Oguz FS, Yalman N, Diler AS, Kalayoglu S, Anak S, Sargin D, Carin M.

Leuk Res. 2002 Jul;26(7):651-6.

PMID:
12008082
4.

[Class I and II HLA antigens in children with acute lymphoblastic leukemia].

Timonova LA, Rumiantsev AG.

Gematol Transfuziol. 1989 May;34(5):19-22. Russian.

PMID:
2744385
5.

[Research on myasthenia gravis in children with HLA supratype].

Zhang XG.

Zhonghua Shen Jing Jing Shen Ke Za Zhi. 1992 Dec;25(6):358-60, 385. Chinese.

PMID:
1305001
6.

[Human leukocyte antigens A and B in Turkish patients with sarcoidosis].

Celik G, Sen ES, Ulger AF, Ozdemir-Kumbasar O, Alper D, Elhan AH, Tutkak H, Cetinyürek A.

Arch Bronconeumol. 2004 Oct;40(10):449-52. Spanish.

7.

HLA-A11 is associated with poor prognosis in childhood acute lymphoblastic leukemia (ALL).

Orgad S, Cohen IJ, Neumann Y, Vogel R, Kende G, Ramot B, Zaizov R, Gazit E.

Leukemia. 1988 Dec;2(12 Suppl):79S-87S.

PMID:
3199882
8.

[Analysis of HLA haplotype frequency and linkage disequilibrium in patients with acute lymphoblastic leukemia from Northern Chinese Han].

Gao SQ, Cheng LH, Lu L, Jing SZ, Cheng X, Zhang YZ, Zou HY, Deng ZH.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009 Feb;26(1):82-6. doi: 10.3760/cma.j.issn.1003-9406.2009.01.019. Chinese.

PMID:
19199259
9.

Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of "isolated" and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group.

Hagedorn N, Acquaviva C, Fronkova E, von Stackelberg A, Barth A, zur Stadt U, Schrauder A, Trka J, Gaspar N, Seeger K, Henze G, Cavé H, Eckert C; Resistant Disease Committee of the International BFM study group..

Blood. 2007 Dec 1;110(12):4022-9. Epub 2007 Aug 24.

11.

[The HLA-B5 immunogenetic marker in Behçet's disease].

Alekberova ZS, Madanat VIa, Polianskaia IS, Prokaeva TB.

Ter Arkh. 1993;65(5):12-4. Russian.

PMID:
8036586
12.

[Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group].

Skoczeń S, Balwierz W, Moryl-Bujakowska A, Pawińska K, Luszczyńska A, Balcerska A, Płoszyńska A, Chybicka A, Dobaczewski G, Juszczak K, Wachowiak J, Derwich K, Kowalczyk J, Wiśniewska-Slusarz H, Matysiak M, Krauze A, Pawelec K, Sońta-Jakimczyk D, Tomaszewska R, Wysocki M, Styczyńskii J, Swiatkiewicz V; Polish Pediatric Leukemia/Lymphoma Study Group..

Przegl Lek. 2006;63(1):11-4. Polish.

PMID:
16892892
13.

Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia.

Choi J, Hwang YK, Sung KW, Lee SH, Yoo KH, Jung HL, Koo HH, Kim HJ, Kang HJ, Shin HY, Ahn HS.

Blood. 2007 Jan 15;109(2):471-7. Epub 2006 Sep 21.

14.

Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation.

Godder KT, Henslee-Downey PJ, Mehta J, Park BS, Chiang KY, Abhyankar S, Lamb LS.

Bone Marrow Transplant. 2007 Jun;39(12):751-7. Epub 2007 Apr 23.

PMID:
17450185
15.

HLA and longevity or aging among Shanghai Chinese.

Ma YX, Zhu Y, Wang ZS, Wang CF, Chen SY, Zhao MT, Zhang GL, Zheng SQ, Zhang JG, Gu Q, He L.

Mech Ageing Dev. 1997 Mar;94(1-3):191-8.

PMID:
9147371
16.

HLA class 1 associations in Henoch Schonlein purpura: increased and decreased frequencies.

Peru H, Soylemezoglu O, Gonen S, Cetinyurek A, Bakkaloğlu SA, Buyan N, Hasanoglu E.

Clin Rheumatol. 2008 Jan;27(1):5-10. Epub 2007 May 9.

PMID:
17487448
17.

Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.

Manabe A, Ohara A, Hasegawa D, Koh K, Saito T, Kiyokawa N, Kikuchi A, Takahashi H, Ikuta K, Hayashi Y, Hanada R, Tsuchida M; Tokyo Children's Cancer Study Group..

Haematologica. 2008 Aug;93(8):1155-60. doi: 10.3324/haematol.12365. Epub 2008 Jun 2.

18.

Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.

Harker-Murray PD, Thomas AJ, Wagner JE, Weisdorf D, Luo X, DeFor TE, Verneris MR, Dusenbery KE, MacMillan ML, Tolar J, Baker KS, Orchard PJ.

Biol Blood Marrow Transplant. 2008 Jun;14(6):685-92. doi: 10.1016/j.bbmt.2008.03.011.

19.

Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.

Bader P, Kreyenberg H, Henze GH, Eckert C, Reising M, Willasch A, Barth A, Borkhardt A, Peters C, Handgretinger R, Sykora KW, Holter W, Kabisch H, Klingebiel T, von Stackelberg A; ALL-REZ BFM Study Group..

J Clin Oncol. 2009 Jan 20;27(3):377-84. doi: 10.1200/JCO.2008.17.6065. Epub 2008 Dec 8.

PMID:
19064980
20.

HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.

Varga M, Rajczy K, Telkes G, Hídvégi M, Péter A, Remport A, Korbonits M, Fazakas J, Toronyi E, Sárváry E, Kóbori L, Járay J.

Nephrol Dial Transplant. 2008 Aug;23(8):2673-8. doi: 10.1093/ndt/gfn111. Epub 2008 Mar 10.

PMID:
18332066

Supplemental Content

Support Center